Drilldown: Medicines
Medicines > onset 
:
Clinical improvement within 24-72 hours or
Postprandial glucose effect within days; HbA1c by 12 weeks
& duration:
24 hours
:
Clinical improvement within 24-72 hours or
Postprandial glucose effect within days; HbA1c by 12 weeks
& duration:
24 hours Use the filters below to narrow your results.
generic:
brand:
classes:
mechanism:
None (2) ·
'"`UNIQ--vote-00000762-QINU`"' Largely renally cleared, hence the eGFR-tiered dosing. Rare but well-documented signals: acute pancreatitis (uncertain causal contribution), severe joint pain, and bullous pemphigoid (class effect, especially in older Asian patients)'"`UNIQ--ref-00000763-QINU`"'. (1)
uses:
starting dose:
100 mg PO once daily (50 mg if CrCl 30-44; 25 mg if <30 or dialysis) (1) ·
5 mg PO once daily (no renal dose adjustment, unlike sitagliptin) (1) ·
Vulvovaginal: 150 mg PO single dose; oropharyngeal: 200 mg PO day 1, then 100 mg daily ×14 days; invasive candidiasis: 800 mg load, then 400 mg PO/IV daily; cryptococcal meningitis: 400-800 mg/d (1)
preparations:
fda max:
onset: (Click arrow to add another value)
duration: (Click arrow to add another value)
halflife:
bioavailability:
pregnancy:
Showing below up to 3 results in range #1 to #3.